New data reveals impact of deadly human papillomavirus in Latin America, Caribbean Thirty-three thousand women in Latin America and the Caribbean die each year of preventable cervical cancer, caused by a virus that infects 20% of men and women in the region and as many as 30% of the youngest women, according to a new study. 14 May 2008 09:59
Bone metastases: can you teach an old drug new tricks? Advanced cancers become largely incurable once they have spread, or metastasised to the bone. Patients affected with bone metastases require supportive therapy in addition to anti-cancer treatment to manage skeletal complications. However, while the bisphosphonates currently used to treat bone metastases reduce the risk of skeletal complications such as bone pain and fractures, they offer no survival benefit in the majority of patients. However, bisphosphonates may effectively prevent bone metastases in early stage cancer patients, which could potentially revolutionise the management of this advance complication, according to a new report* by independent market analyst Datamonitor. 14 May 2008 08:34
Blogging to bust cancer myths The misinformation and confusion that often hovers around health and science stories will soon be dispelled by top science bloggers at Cancer Research UK. 14 May 2008 07:36
Physical activity protects some women from breast cancer A recent study published in the British Journal of Sports Medicine reports that physically active women are 25% less likely to develop breast cancer. 13 May 2008 09:59
Sunbeds can prove fatal Eight out of ten sunbed users have increased their risk of a life-threatening form of skin cancer by around 75% according to Cancer Research UK. 10 Apr 2008 10:23
Researchers learn how signalling molecule orchestrates breast cancer's spread A study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) has uncovered how breast tumours use a particular type of molecule to promote metastasis – the spread of cancer cells. Metastasis is the cause of approximately 90% of all cancer-related deaths. 7 Apr 2008 07:32
Herceptin approved for HER2-positive early breast cancer Roche, one of the world's leading oncology companies, has announced that its life-saving HER2-targeted IV therapy, Herceptin® (trastuzumab), for HER2-positive breast cancer, has been approved by the South African Regulatory Authority: Medicines Control Council (MCC) for early breast cancer. 3 Apr 2008 17:32
Chemotherapy-induced anaemia increases risk of local breast cancer recurrence Patients with breast cancer who developed anaemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. 3 Apr 2008 07:56